4//SEC Filing
Nexvet Biopharma plc 4
Accession 0001572426-15-000129
CIK 0001618561operating
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 1:10 PM ET
Size
8.1 KB
Accession
0001572426-15-000129
Insider Transaction Report
Form 4
Heffernan Mark
Chief Executive Officer
Transactions
- Exercise/Conversion
Option to Purchase Shares
2015-11-20−9,204→ 9,203 total(indirect: By Mark Andrew and Patricia Louise Heffernan <M&T Heffernan A/C>)Exercise: $0.13Exp: 2020-11-05→ Ordinary Shares (9,204 underlying) - Exercise/Conversion
Ordinary Shares
2015-11-20$0.13/sh+9,204$1,151→ 243,587 total(indirect: By Mark Andrew and Patricia Louise Heffernan <M&T Heffernan A/C>)
Holdings
- 12,084
Ordinary Shares
Footnotes (2)
- [F1]The reporting person and his spouse share voting and dispositive power with respect to these reported securities.
- [F2]Options to purchase 9,204 shares vested and became exercisable on 11/5/15, and the remaining 9,203 options to purchase shares will vest and become exercisable on 11/5/16.
Documents
Issuer
Nexvet Biopharma plc
CIK 0001618561
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001618561
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 1:10 PM ET
- Size
- 8.1 KB